Latest filing published 14 Sept 2023 for Bone Biologics Corp, €4,770.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -67.1%Entry US$34.51 · Close at T+365 US$11.34
- -79.3%Entry US$32.98 · Close at T+365 US$6.84
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Deina H. Walsh: trading record in brief
Deina H. Walsh appears in our data through filings on Bone Biologics Corp shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 6 September 2023 to 13 September 2023.
On the market, this insider has only ever bought: 3 purchases, €9,401 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €4,436 and half below. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of -36.0%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
The latest filing, published on 14 September 2023, reports an open-market purchase of €4,770 in Bone Biologics Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Deina H. Walsh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares@ US$0.6496.1% of flowCommon StockSEC:0001493152-23-032583:0Canonical exit: 12 Dec 2023 (T+90)
- 6,700 shares@ US$0.7147.2% of flowCommon StockSEC:0001493152-23-031935:1Canonical exit: 5 Dec 2023 (T+90)
- 300 shares@ US$0.703.9% of flowCommon StockSEC:0001493152-23-031935:0Canonical exit: 5 Dec 2023 (T+90)
3 of 3 declarations